Search
Rxsight Inc
RXSTAdd to Watchlist
5.610USD
+0.440+8.51%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
232.23MMarket Cap
LossP/E TTM
More Details of Rxsight Inc Company
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Rxsight Inc Info
Ticker SymbolRXST
Company nameRxsight Inc
IPO dateJul 30, 2021
CEOKurtz (Ron M)
Number of employees498
Security typeOrdinary Share
Fiscal year-endJul 30
Address100 Columbia Street
CityALISO VIEJO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92656
Phone19495217822
Websitehttps://www.rxsight.com/
Ticker SymbolRXST
IPO dateJul 30, 2021
CEOKurtz (Ron M)
Company Executives of Rxsight Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%
FAQs
Who are the top five shareholders of Rxsight Inc?
The top five shareholders of Rxsight Inc are: Mr. Eric Weinberg
How many institutions hold shares of Rxsight Inc (RXST)?
As of 2026Q1, 467 institutions hold shares of Rxsight Inc, with a combined market value of approximately 38.60M, accounting for 93.24% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -10991579.00.